Author | Lynda Charters

5 MOBILE INFIRMARY CIR

Articles

TENAYA, LUCERNE trials show faricimab reaches primary endpoints

Robyn Guymer, PhD, MBBS, highlights the latest trial results for faricimab, the first bispecific antibody designed for intraocular use in treating patients with neovascular age-related macular degeneration.

ESCRS 2019: What delegates can expect at this year’s congress